Autism Inpatient Collection (AIC) is a study designed to produce a collection of phenotypic and genetic data from children with a clinical diagnosis of autism who have been admitted to one of six specialized inpatient child psychiatry units in the United States.
Today, we’re announcing our annual request for applications (RFA) for SFARI Pilot and Research Awards. Letters of intent (LOIs), the short statements that precede full applications, are due no later than 9 October, 2015. As we do every year, we’ve updated this column to provide a better picture of how the SFARI science team makes decisions on research proposals.
On 2 September, we plan to announce a new request for applications. Letters of intent, the short statements that precede full applications, are due no later than 10 October. It seems timely, therefore, to describe how we make decisions on research proposals.
Today, we’re announcing a new request for applications. Letters of intent, the short statements that precede full applications, are due no later than 11 October. It seems timely, therefore, to describe how we make decisions on research proposals.
In this blog post, the SFARI science team provides insight into SFARI’s scientific priorities. A number of experimental design issues to consider when preparing a grant application in response to the 2017 Pilot and Research Awards RFA are also discussed.
New genetic variants that increase susceptibility to autism are emerging at a rapid pace. Given the profusion of data, it seems timely to assess the availability and usefulness of mouse models in which to study these genetic risk factors.
Which grant applications should SFARI choose to fund each year? The principles that guide that decision are nuanced and evolve as new results emerge. But there are some clear general guidelines in place, says John Spiro, SFARI’s deputy scientific director.
In November, the Simons Foundation Autism Research Initiative (SFARI) launched a request for applications, calling for letters of intent from individuals who will conduct bold, imaginative and rigorous research relevant to our mission. Applicants received notice in late February indicating whether they should submit a full application. Here, John Spiro, SFARI’s senior associate director for research, attempts to demystify the grant-making process — and give readers a behind-the-scenes look at how SFARI’s science team makes decisions.
SFARI is pleased to announce that it has awarded five grants in response to the Whole-Genome Analysis for Autism Risk Variants request for applications. We are also announcing plans for the release of whole-genome sequencing data from the Simons Simplex Collection (SSC) for analysis by the entire research community.
- Previous Page
- Viewing
- Next Page